BioSpace News Archive

With promising results on its first rheumatological protein therapies, Dianomi is strategically expanding upon its core technology to deliver next-generation nucleic acid therapies

Deal marks IAC’s official entry into the $300 billion family care market

Devonian Health Group Inc. announced it has signed an exclusive sales and marketing agreement with SkinSciPac Inc. to market worldwide cosmeceutical products derived from usage of its proprietary R-Spinasome® technology.

TauC3 Biologics Limited and Life Arc have been selected by the Tau2020 Global Conference Program Committee to present at Tau2020, being held in Washington, D.C., February 12-13, 2020.

Autism Learning Partners and Cognoa announced a partnership designed to accelerate the diagnosis of autism to enable interventions earlier, when there is the greatest potential to improve lifelong outcomes.

DOYLESTOWN, Pa., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (OTCQB: KLFE) (“Kannalife” or the “Company”), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, announced today that it has completed its phase 1 study funded by a grant (1R41DA044898-01) from the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA) . The study was performed by Kannalife and the Lewis Katz School of Medicine at Temple Universi

Reccently, the demand for medical devices such as protective clothing and masks soared, as did demand for devices including POCT testing reagents for the IVD industry, nucleic acid extraction devices, gene sequencing technology, medical imaging devices such as CT scanners; monitoring devices such as ECG monitors and blood gas analyzers; ICU products such as ventilators and ECMO; and medical robots.

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., welcomes Gail R. Wilensky, Ph.D., to the Council of Directors.

The American Urological Association and the Urology Care Foundation—the official foundation of the AUA— have recognized 21 researchers as recipients of the 2020 Urology Care Foundation Research Scholar Awards.

RedHawk Holdings Corp. ( OTC: SNDD ) (“RedHawk” or the “Company”) a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial s